Aspirin Exacerbated Respiratory Disease Market Share

Regionally, the global aspirin exacerbated respiratory disease market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. North America industry is set to hold largest revenue share by 2036, propelled by presence of a plethora of pharmaceutical companies. It is estimated that in the USA alone there are 2100 pharmaceutical manufacturing businesses. Furthermore, asthma patients in the region are also drastically increasing. The data released by the Asthma and Allergy Foundation of America states that approximately 25 million people in the USA have asthma. The surging asthma cases in the North America region are anticipated to propel the global market growth during the forecast period.

The Asia Pacific region is also estimated to offer lucrative opportunities for the growth of the global aspirin exacerbated respiratory disease market during the forecast period. The region is highly populous and large economies such as, India and China are allotting humongous budgets to the health care sector. Furthermore, the report published by the WHO states that 1 in every 10 asthma patients globally is living in India. Hence the rising cases of asthma are also projected to foster regional growth.